Capricor Therapeutics
CAPR
$4.64
Share price
-3.13%
Change (1 day)
-5.69%
Change (1 year)
Categories
Market capitalization of Capricor Therapeutics (CAPR)
Market cap: $0.14 Billion
As of June 2024 Capricor Therapeutics has a market cap of $0.14 Billion. This makes Capricor Therapeutics the world's 7177th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Capricor Therapeutics from 2002 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.14 B | -1.46% |
| 2023 | $0.15 B | 54.55% |
| 2022 | $97.43 M | 37.7% |
| 2021 | $70.75 M | 0.89% |
| 2020 | $70.13 M | 948.19% |
| 2019 | $6.69 M | -48.01% |
| 2018 | $12.86 M | -68.32% |
| 2017 | $40.62 M | -28.64% |
| 2016 | $56.92 M | 13.93% |
| 2015 | $49.96 M | 13.8% |
| 2014 | $43.9 M | 15.58% |
| 2013 | $37.98 M | 1711.3% |
| 2012 | $2.09 M | -90.31% |
| 2011 | $21.64 M | 0.79% |
| 2010 | $21.47 M | -34.49% |
| 2009 | $32.77 M | 59.66% |
| 2008 | $20.52 M | -84.51% |
| 2007 | $0.13 B | 4288.98% |
| 2006 | $3.02 M | -38.46% |
| 2005 | $4.9 M | 0% |
| 2004 | $4.9 M | 27.45% |
| 2003 | $3.85 M | -63.57% |
| 2002 | $10.57 M |
End of Day market cap according to different sources
On Jun 25th, 2024 the market cap of Capricor Therapeutics was reported to be:
$0.14 Billion
$0.14 Billion
$0.14 Billion
$0.14 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $354.23 B | 238,631.51% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | $13.59 B | 9,061.40% | 🇺🇸 USA |
 Cytokinetics
CYTK | $6.19 B | 4,075.33% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $2.38 B | 1,508.41% | 🇺🇸 USA |
 Palatin Technologies PTN | $29.2 M | -80.32% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $9.84 M | -93.37% | 🇺🇸 USA |